SCHEMBL27978052

SCHEMBL27978052

CCc1ncc2c(n1)NCC(N)=N2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27978057 0.72 XIAP (0.38) —
SCHEMBL3780127 0.67 BRPF1 (0.43) —
SCHEMBL4930097 0.63 DHFR (0.45) —
SCHEMBL2632836 0.61 PDE3B (0.41) —
SCHEMBL24197705 0.60 HTR2C (0.34) —
SCHEMBL30278027 0.60 GRM5 (0.38) —
SCHEMBL1649702 0.60 — —
SCHEMBL28012718 0.60 ADORA1 (0.33) —
SCHEMBL16479902 0.60 GABRP (0.41) —
SCHEMBL15538133 0.59 NOS2 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101484457-B 4, 5-dihydro- [1,2,4] triazolo [4,3-f ] pteridines as protein kinase PLK1 inhibitors for the treatment of proliferative disorders VERTEX PHARMA 2014-09-03 — — CN disclosed
Send feedback